HAGA:OMXICEHagar hf. Analysis

The stock is trading at 1,637 ILA, comfortably above its 20‑day (1,473) and 50‑day (1,496) simple moving averages. A bullish MACD crossover (line 35.3 above signal 13.9) reinforces the upward bias. However, the 14‑day RSI sits at 66, edging into overbought territory. The price is positioned near the upper technical range, with a key resistance at 1,718 and a solid support around 1,303. Trading volume has been tapering, falling short of the 10‑day average of 74,222 shares. The 30‑day volatility of nearly 59% signals a highly erratic price environment, while the beta of 0.58 suggests limited correlation with the broader market.
On the fundamentals side, revenue of 21.6 million ILA grew only 4.5% year‑over‑year, yet operating margins are –21% and net profit margins –16%, indicating a loss‑making operation. EBITDA remains positive at 13.6 million, but cash flow is negative, with operating cash outflows of –14.1 million and free cash flow of –20.9 million. The balance sheet is heavily leveraged, featuring 158 million ILA of debt against just 29 million ILA of cash, yielding a debt‑to‑equity ratio above 166. The price‑to‑book of 14.6× and price‑to‑sales of 49.9× dwarf industry averages, flagging a pronounced overvaluation. No dividend is paid, and ROE is –4%, further eroding the attractiveness for income‑focused investors. The “Extreme Greed” reading on the Fear & Greed Index underscores speculative sentiment that may be unsustainable. Combined, the technical upside is outweighed by weak earnings, high leverage, and lofty multiples, painting a cautionary picture for investors.